Search

Your search keyword '"Garcia-Cehic, D."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Garcia-Cehic, D." Remove constraint Author: "Garcia-Cehic, D."
49 results on '"Garcia-Cehic, D."'

Search Results

1. Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain

2. Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment

3. Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype

4. Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

5. Comparison of Nanopore and Synthesis-Based Next-Generation Sequencing Platforms for SARS-CoV-2 Variant Monitoring in Wastewater

6. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

7. High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping

8. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients

9. Characterization of intra- and inter-host norovirus P2 genetic variability in linked individuals by amplicon sequencing

10. Viral load at 15 days after liver transplantation as a good predictor of fast liver fibrosis progression

11. P0704 : Deep-sequencing analysis demonstrates the persistence of the pre-transplant HCV dominant variant within a more homogeneous quasispecies after liver transplantation in cholestatic hepatitis C patients

13. P657 IN VIVO MUTAGENIC EFFECT OF RIBAVIRIN ON SUBTYPE 3F HEV QUASISPECIES ISOLATED FROM A PATIENT INFECTED FROM PORK MEAT

14. P1110 HIGH-RESOLUTION HCV SUBTYPING USING MASSIVE SEQUENCING AND PHYLOGENY, OPTIMAL ALTERNATIVE TO CURRENT METHODS

15. Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome

17. 1324 QUASISPECIES HOMOGENIZATION AND IL-28 GENOTYPE (RS12979860 AND RS8099917) MAY FAVOUR SELF-RESOLVING INFECTION AFTER HCV BOTTLENECKING TRANSMISSION

18. 336 DETECTION OF CLINICALLY RELEVANT MINOR HCV AND HBV ANTIVIRAL-RESISTANT MUTANTS IN TREATMENT-NAIVE PATIENTS USING ULTRA-DEEP PYROSEQUENCING

19. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

20. Bioinformatic Tools for NGS-Based Metagenomics to Improve the Clinical Diagnosis of Emerging, Re-Emerging and New Viruses

21. The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants

22. Host-dependent editing of SARS-CoV-2 in COVID-19 patients

23. Next-Generation Sequencing for Confronting Virus Pandemics

24. Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients

25. Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype

26. In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications.

27. Complete Genome Sequences of Four Mycobacteriophages Involved in Directed Evolution against Undisputed Mycobacterium abscessus Clinical Strains.

28. In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments.

29. Comparison of Nanopore and Synthesis-Based Next-Generation Sequencing Platforms for SARS-CoV-2 Variant Monitoring in Wastewater.

30. Bioinformatic Tools for NGS-Based Metagenomics to Improve the Clinical Diagnosis of Emerging, Re-Emerging and New Viruses.

31. Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient.

32. Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach.

33. Next-Generation Sequencing for Confronting Virus Pandemics.

34. Host-dependent editing of SARS-CoV-2 in COVID-19 patients.

35. Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients.

36. Monitoring Emergence of the SARS-CoV-2 B.1.1.7 Variant through the Spanish National SARS-CoV-2 Wastewater Surveillance System (VATar COVID-19).

37. Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure.

38. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.

39. Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: Implications for immunization policies.

41. Characterization of intra- and inter-host norovirus P2 genetic variability in linked individuals by amplicon sequencing.

42. New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors.

43. Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing.

44. New real-time-PCR method to identify single point mutations in hepatitis C virus.

45. Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods.

46. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.

47. Ultra-deep pyrosequencing (UDPS) data treatment to study amplicon HCV minor variants.

48. Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome.

49. Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system.

Catalog

Books, media, physical & digital resources